Merck shares plunge as company pauses Gardasil vaccine shipments in China, hurting 2025 outlook
Merck’s full-year 2025 revenue guidance fell short of what some analysts were expecting, at a range of $64.1 billion to $65.6 billion.
Demi Moore, Adrien Brody and Jean Smart won big Sunday at the 82nd Golden Globes. The 2025 Golden Globes featured a star-studded roster with Selena Gomez, Ariana Grande and Sharon Stone dazzling on the red carpet at the Beverly Hilton Hotel in the heart of Beverly Hills, Calif. Here’s the complete list of winners from…
The number of people injured following the plane crash in Philadelphia has increased to 24, with four still hospitalized. Mayor Cherelle L. Parker stood alongside other officials during an update Monday afternoon about the latest on the medical jet crash investigation. Two of the four still in the hospital are in critical condition, and two…
The Federal Reserve’s key measure of inflation cooled slightly in January. The personal consumption expenditures price index, which measures price changes for consumers, rose .3% since last month and 2.5% since this time last year. CBS News MoneyWatch correspondent Kelly O’Grady reports.
Ravichandran Ashwin, one of India’s finest spinners, retired from international cricket after a 14-year career. He finished with 537 Test wickets, second only to Anil Kumble in Indian cricket history. While Kumble holds the record for most wickets, Ashwin achieved milestones faster and boasts superior bowling averages and strike rates.
CD interest rates could soon drop. Here’s why you should deposit $5,000 into a long-term CD before that happens.
The Indian Patent Office has rejected Viiv Healthcare’s patent application for the HIV drug, dolutegravir, after nearly a decade of legal battles. This decision opens the market for generic versions, promoting affordable access to treatment and potentially reducing costs. The ruling addresses concerns over ‘evergreening’ practices in patent filings.